tiprankstipranks
Niagen Bioscience, Inc. (NAGE)
NASDAQ:NAGE
US Market
NAGE
Niagen Bioscience
RESEARCH TOOLSreports
Want to see NAGE full AI Analyst Report?

Niagen Bioscience (NAGE) Ratios

658 Followers

Niagen Bioscience Ratios

NAGE's free cash flow for Q1 2026 was $0.63. For the 2026 fiscal year, NAGE's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.61 4.86 3.57 2.40 2.61
Quick Ratio
 3.55 3.83 3.06 1.70 1.78
Cash Ratio
 2.92 3.25 2.48 1.32 1.14
Solvency Ratio
 0.64 0.63 0.45 -0.12 -0.58
Operating Cash Flow Ratio
 0.19 0.67 0.67 0.35 -0.84
Short-Term Operating Cash Flow Coverage
 4.24 13.41 0.00 0.00 0.00
Net Current Asset Value
$ 73.12M$ 66.93M$ 41.92M$ 23.03M$ 21.18M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.03 0.04 0.06 0.08
Debt-to-Equity Ratio
 0.03 0.04 0.06 0.12 0.15
Debt-to-Capital Ratio
 0.03 0.04 0.05 0.10 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.39 1.39 1.48 1.93 1.89
Debt Service Coverage Ratio
 11.93 14.91 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.03 0.04 0.03 0.05 0.06
Net Debt to EBITDA
 -4.79 -3.94 -4.54 6.14 0.96
Profitability Margins
Gross Profit Margin
64.28%64.28%61.84%60.76%59.40%
EBIT Margin
8.94%11.05%7.76%-6.70%-25.85%
EBITDA Margin
10.25%12.17%9.25%-4.66%-23.24%
Operating Profit Margin
8.51%11.05%7.76%-6.70%-25.85%
Pretax Profit Margin
15.10%14.06%8.89%-5.91%-22.96%
Net Profit Margin
14.29%13.43%8.58%-5.91%-22.96%
Continuous Operations Profit Margin
14.29%13.43%8.58%-5.91%-22.96%
Net Income Per EBT
94.62%95.55%96.56%100.00%100.00%
EBT Per EBIT
177.44%127.25%114.61%88.19%88.79%
Return on Assets (ROA)
16.30%16.34%12.52%-8.98%-30.60%
Return on Equity (ROE)
25.38%22.71%18.55%-17.35%-57.69%
Return on Capital Employed (ROCE)
12.13%16.53%15.35%-16.30%-51.48%
Return on Invested Capital (ROIC)
11.35%15.61%14.53%-15.98%-50.50%
Return on Tangible Assets
17.12%17.25%12.59%-9.07%-30.98%
Earnings Yield
6.37%3.45%1.88%-4.90%-14.29%
Efficiency Ratios
Receivables Turnover
 9.98 13.29 12.82 15.97 8.49
Payables Turnover
 3.51 4.28 4.46 3.20 3.02
Inventory Turnover
 1.94 2.26 4.14 2.26 1.99
Fixed Asset Turnover
 39.32 36.82 28.88 18.42 11.40
Asset Turnover
 1.14 1.22 1.46 1.52 1.33
Working Capital Turnover Ratio
 1.64 2.10 2.65 2.90 2.40
Cash Conversion Cycle
 120.72 103.48 34.86 70.65 105.33
Days of Sales Outstanding
 36.57 27.47 28.47 22.86 42.97
Days of Inventory Outstanding
 188.18 161.24 88.27 161.68 183.13
Days of Payables Outstanding
 104.03 85.23 81.87 113.90 120.77
Operating Cycle
 224.75 188.71 116.73 184.54 226.10
Cash Flow Ratios
Operating Cash Flow Per Share
 0.05 0.17 0.14 0.10 -0.22
Free Cash Flow Per Share
 0.05 0.17 0.14 0.10 -0.22
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.93 0.98 0.99 0.98 1.02
Dividend Paid and CapEx Coverage Ratio
 13.62 46.02 74.29 48.09 -45.20
Capital Expenditure Coverage Ratio
 13.62 46.02 74.29 48.09 -45.20
Operating Cash Flow Coverage Ratio
 1.70 4.77 4.57 2.17 -3.55
Operating Cash Flow to Sales Ratio
 0.03 0.10 0.12 0.09 -0.21
Free Cash Flow Yield
1.39%2.61%2.63%6.91%-13.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.69 28.97 53.05 -20.43 -7.00
Price-to-Sales (P/S) Ratio
 2.24 3.89 4.55 1.21 1.61
Price-to-Book (P/B) Ratio
 3.55 6.58 9.84 3.54 4.04
Price-to-Free Cash Flow (P/FCF) Ratio
 71.96 38.31 37.97 14.48 -7.50
Price-to-Operating Cash Flow Ratio
 66.90 37.48 37.46 14.17 -7.67
Price-to-Earnings Growth (PEG) Ratio
 0.56 0.24 -0.22 0.29 0.17
Price-to-Fair Value
 3.55 6.58 9.84 3.54 4.04
Enterprise Value Multiple
 17.02 28.05 44.71 -19.77 -5.96
Enterprise Value
 227.53M 441.60M 411.74M 76.98M 99.75M
EV to EBITDA
 17.02 28.05 44.71 -19.77 -5.96
EV to Sales
 1.74 3.41 4.13 0.92 1.38
EV to Free Cash Flow
 56.17 33.59 34.47 11.05 -6.46
EV to Operating Cash Flow
 52.04 32.86 34.00 10.82 -6.61
Tangible Book Value Per Share
 0.96 0.90 0.54 0.40 0.41
Shareholders’ Equity Per Share
 1.03 0.97 0.54 0.40 0.42
Tax and Other Ratios
Effective Tax Rate
 0.05 0.04 0.03 0.00 0.00
Revenue Per Share
 1.63 1.63 1.17 1.18 1.05
Net Income Per Share
 0.23 0.22 0.10 -0.07 -0.24
Tax Burden
 0.95 0.96 0.97 1.00 1.00
Interest Burden
 1.69 1.27 1.15 0.88 0.89
Research & Development to Revenue
 0.05 0.05 0.06 0.06 0.07
SG&A to Revenue
 0.51 0.48 0.48 0.30 0.39
Stock-Based Compensation to Revenue
 0.01 0.00 0.04 0.06 0.08
Income Quality
 0.23 0.77 1.42 -1.44 0.91
Currency in USD